1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/01/2024 | CTVA | Buy Now | Corteva | $57.00 | — | Wolfe Research | Chris Parkinson | — | Initiates | → Outperform | Get Alert |
02/12/2024 | CTVA | Buy Now | Corteva | $57.00 | 14.04% | Loop Capital | Christopher Kapsch | $57 → $65 | Upgrade | Hold → Buy | Get Alert |
02/02/2024 | CTVA | Buy Now | Corteva | $57.00 | 8.77% | Oppenheimer | Kristen Owen | $60 → $62 | Maintains | Outperform | Get Alert |
02/02/2024 | CTVA | Buy Now | Corteva | $57.00 | 12.28% | RBC Capital | Arun Viswanathan | $56 → $64 | Maintains | Outperform | Get Alert |
02/02/2024 | CTVA | Buy Now | Corteva | $57.00 | 10.53% | Keybanc | Aleksey Yefremov | $62 → $63 | Maintains | Overweight | Get Alert |
02/02/2024 | CTVA | Buy Now | Corteva | $57.00 | 14.04% | Wells Fargo | Richard Garchitorena | $54 → $65 | Maintains | Overweight | Get Alert |
02/02/2024 | CTVA | Buy Now | Corteva | $57.00 | -3.51% | Barclays | Benjamin Theurer | $50 → $55 | Maintains | Equal-Weight | Get Alert |
02/02/2024 | CTVA | Buy Now | Corteva | $57.00 | -7.02% | Exane BNP Paribas | Laurent Favre | → $53 | Upgrade | Underperform → Neutral | Get Alert |
02/01/2024 | CTVA | Buy Now | Corteva | $57.00 | -1.75% | Mizuho | Chris Parkinson | $59 → $56 | Maintains | Buy | Get Alert |
01/11/2024 | CTVA | Buy Now | Corteva | $57.00 | 12.28% | UBS | Joshua Spector | $65 → $64 | Maintains | Buy | Get Alert |
11/27/2023 | CTVA | Buy Now | Corteva | $57.00 | -8.77% | Berenberg | Aron Ceccarelli | $63 → $52 | Downgrade | Buy → Hold | Get Alert |
11/22/2023 | CTVA | Buy Now | Corteva | $57.00 | 10.53% | Roth MKM | Brian Wright | $82 → $63 | Maintains | Buy | Get Alert |
11/14/2023 | CTVA | Buy Now | Corteva | $57.00 | -12.28% | Barclays | Benjamin Theurer | $66 → $50 | Downgrade | Overweight → Equal-Weight | Get Alert |
11/10/2023 | CTVA | Buy Now | Corteva | $57.00 | -1.75% | RBC Capital | Arun Viswanathan | $61 → $56 | Maintains | Outperform | Get Alert |
11/10/2023 | CTVA | Buy Now | Corteva | $57.00 | 5.26% | Morgan Stanley | Vincent Andrews | $80 → $60 | Maintains | Overweight | Get Alert |
11/10/2023 | CTVA | Buy Now | Corteva | $57.00 | 8.77% | Keybanc | Aleksey Yefremov | $66 → $62 | Maintains | Overweight | Get Alert |
10/30/2023 | CTVA | Buy Now | Corteva | $57.00 | 1.75% | Fermium Research | Frank Mitsch | $72 → $58 | Maintains | Outperform | Get Alert |
10/30/2023 | CTVA | Buy Now | Corteva | $57.00 | 7.02% | RBC Capital | Arun Viswanathan | $67 → $61 | Maintains | Outperform | Get Alert |
10/30/2023 | CTVA | Buy Now | Corteva | $57.00 | 12.28% | BMO Capital | Joel Jackson | $70 → $64 | Maintains | Outperform | Get Alert |
The latest price target for Corteva (NYSE: CTVA) was reported by Wolfe Research on March 1, 2024. The analyst firm set a price target for $0.00 expecting CTVA to fall to within 12 months (a possible -100.00% downside). 41 analyst firms have reported ratings in the last year.
The latest analyst rating for Corteva (NYSE: CTVA) was provided by Wolfe Research, and Corteva initiated their outperform rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Corteva, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Corteva was filed on March 1, 2024 so you should expect the next rating to be made available sometime around March 1, 2025.
While ratings are subjective and will change, the latest Corteva (CTVA) rating was a initiated with a price target of $0.00 to $0.00. The current price Corteva (CTVA) is trading at is $57.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.